During the past decade, Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 15 clinical trials were completed, i.e. on average, 88.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 12 clinical trials were completed. i.e. 171.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH" #1 sponsor was "Boehringer Ingelheim" with 21 trials, followed by "University Hospital Heidelberg" with 2 trials sponsored, "Chiesi Farmaceutici S.p.A." with 1 trials sponsored, "Chimerix" with 1 trials sponsored and "EpiEndo Pharmaceuticals" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH" #1 collaborator was "Hannover Medical School" with 2 trials as a collaborator, "Philipps University Marburg Medical Center" with 2 trials as a collaborator, "Chiesi USA, Inc." with 1 trials as a collaborator, "FGK Clinical Research GmbH" with 1 trials as a collaborator and "German Center for Lung Research" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH" are "Pulmonary Disease, Chronic Obstructive" (9 trials), "Chronic Obstructive Pulmonary Disease" (5 trials), "Idiopathic Pulmonary Fibrosis" (5 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials) and "Asthma" (2 trials). Many other conditions were trialed in "Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH" in a lesser frequency.

Most popular intervention types in "Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH" are "Drug" (23 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Nintedanib" (3 trials), "BI 1015550" (2 trials), "Olodaterol" (2 trials) and "Tiotropium" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".